NCT05716958招募中不适用
Multi-Reader, Multi-Case, Cross-Over, Retrospective, Superiority, Pivotal Study to Evaluate Effectiveness of Lunit INSIGHT DBT in the Assistance of Detection and Diagnosis of Breast Cancer During 3D Mammography Interpretation
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- Lunit Inc.
- 入组人数
- 262
- 试验地点
- 1
- 主要终点
- Effectiveness of Lunit INSIGHT DBT
研究概览
简要总结
This study aims to evaluate Effectiveness of Lunit INSIGHT DBT in the assistance of detection and diagnosis of breast cancer during 3D mammography interpretation
详细描述
The primary objective of the trial is to evaluate the effectiveness of Lunit INSIGHT DBT in the assistance of detection and diagnosis of breast cancer by comparing the clinical performance of radiologists before and after using Lunit INSIGHT DBT in their DBT reading and secondarily examining the use of Lunit INSIGHT DBT to shorten DBT reading time.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 22 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •[For All Subject Groups]
- •22 years old or older
- •[For 'Control (Non-cancer)' Group]
- •Negative Cases Interpreted as BI-RADS 0 (Assessment Incomplete) or BI-RADS 1 (Negative) with no cancers on the DBT exam and confirmed as BI-RADS 1 (Negative) on the further diagnostic imaging (e.g., MMG, DBT, MRI, CT and Ultrasound) taken at least after 1 year of the DBT exam.
- •Benign Cases Interpreted as BI-RADS 0 (Assessment Incomplete) or BI-RADS 2 (Benign) with a visible lesion on the DBT exam and confirmed as BI-RADS 2 (Benign) on the further diagnostic imaging (e.g., MMG, DBT, MRI, CT and Ultrasound) taken at least after 1 year of the DBT exam without a further breast biopsy.
- •Or for the biopsy-proven benign exams, interpreted as BI-RADS 0 (Assessment Incomplete), BI-RADS 3 (Probably Benign), 4 (Suspicious) or 5 (Highly Suggestive of Malignancy) with a visible suspicious lesion for breast cancer on the DBT exam but confirmed as benign through subsequent biopsy conducted within following 1 year of the DBT exam.
- •[For 'Condition (Cancer)' Group] Interpreted as BI-RADS 0 (Assessment Incomplete), BI-RADS 3 (Probably Benign), 4 (Suspicious) or 5 (Highly Suggestive of Malignancy) with a visible suspicious lesion for breast cancer on the DBT exam and confirmed as a cancer (malignant) through the subsequent biopsy conducted within following 1 year of the DBT exam.
排除标准
- •Previous breast cancer
- •Previous vacuum-assisted biopsy, surgical biopsy or surgery in breast
- •Presence of a breast implant or pacemaker on the required images: 4 views (RCC, RMLO, LCC, LMLO) images of Screening or diagnostic DBT exams with a FFDM (Full-Field Digital mammography) image or with a synthetic 2D image
结局指标
主要结局
Effectiveness of Lunit INSIGHT DBT
时间窗: 3 months after the 1st tomosynthesis reading
Patient-level LOS (Level of Suspicion) area under the ROC (Receiver Operating Characteristic) curve
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Fujifilm DBT Plus S-View Versus FFDM Alone in the Detection of Breast Cancer - A Pivotal StudyBreast CancerNCT03501693Fujifilm Medical Systems USA, Inc.300
已完成
不适用
Multi-Reader Multi-Case Controlled Clinical Trial to Assess the Fujifilm FFDM and DBT Reader Training ProgramBreast CancerNCT02685566Fujifilm Medical Systems USA, Inc.100
已完成
不适用
Study to Evaluate the Effectiveness of the Device in Detection of Abnormal Findings on X-rayPulmonary DiseaseNCT05619029Lunit Inc.1,111
进行中（未招募）
不适用
Multi-Reader Multi-Case, Retrospective Study to Evaluate Effectiveness of CadAI-B for BreastBreast CancerNCT06352684BeamWorks Inc.1,000
招募中
不适用
Evaluation of Deep Brain Stimulation (DBS) of the Right Operculum 3 (OP3) in Permanent Non-pulsatile Disabling Tinnitus (TINNOP3-DBS)Severe Permanent Uni or Bilateral Non-pulsatile TinnitusWithout Associated Vestibular PathologyResistant to Therapeutic FailureWith or Without Hearing LossNCT04296097University Hospital, Grenoble7